EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sustained antigen-specific CD8+ T cell immunity post–mRNA booster requires notch pathway activation

Takuto Nogimori iD, Yoshinori Okina, Yuji Masuta, Mayu Kumamoto, Tomoka Matsuura, Natsuko Kaku, Satoko Ohfuji, Tetsuo Kase, Kyoko Kondo, Yu Nakagama iD, Sachie Nakagama, Yuko Nitahara und 6 weitere

The Journal of Immunology · 07.06.2026 · 215 (6)

DOI: 10.1093/jimmun/vkag074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 08.06.2026. Verfasst von Takuto Nogimori und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health, and Nut…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Receptors, Notch, BNT162 Vaccine, COVID-19 Vaccines. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural Research Program of the National Institutes of Biomedical Innovation, Health, and Nutrition, Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (B), Ministry of Health, Labour, and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Messenger RNA (mRNA) vaccines effectively induce protective immunity, but antigen-specific CD8+ T cell responses exhibit limited persistence. In this study, we aimed to assess CD8+ T cell responses following a third dose of the Pfizer BNT162b2 COVID-19 vaccine and identify factors contributing to their longevity. Using HLA tetramers, we analyzed antigen-specific CD8+ T cells in 141 vaccinated individuals (86.5% female) and identified 2 groups: those with strong responses (strong group) and those with weak responses (weak group) 6 mo after the third mRNA vaccination. Transcriptomic analysis revealed that Notch signaling was upregulated in the strong group, and in vitro, the inhibition of Notch signaling significantly reduced CD8+ T cell expansion. These findings suggest that Notch signaling may contribute to maintain long-term antigen-specific CD8+ T cell responses following mRNA vaccination. Targeting this pathway could offer novel strategies for enhancing vaccine-induced cellular immunity and long-lasting protection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesReceptors, NotchBNT162 VaccineCOVID-19 VaccinesHumansFemaleSignal TransductionMaleImmunization, SecondaryImmunity, CellularRNA, MessengerAdult

Stichwörter der Autor:innen

mRNA vaccinememory T cellsnotch signalingspike-specific CD8+ T cells

Substanzen

Receptors, NotchBNT162 VaccineRNA, MessengerCOVID-19 Vaccines

Autor:innen und Institutionen

  • Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health, and Nutrition, Osaka, Japan.
  • Laboratory of Aging and Immune Regulation, Graduate School of Pharmaceutical Sciences, The University of Osaka, Osaka, Japan.
  • Department of Public Health, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
  • Research Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
  • Department of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
  • OMU Core Facilities Life Sciences Section, Osaka Metropolitan University, Osaka, Japan.

ORCID-Profile: Takuto Nogimori, Yu Nakagama, Wakaba Fukushima, Yasutoshi Kido, Takuya Yamamoto

Förderung

  • Intramural Research Program of the National Institutes of Biomedical Innovation, Health, and Nutrition
  • Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (B)
  • Ministry of Health, Labour, and Welfare

Zitieren

APA

Nogimori, T., Okina, Y., Masuta, Y., Kumamoto, M., Matsuura, T., Kaku, N., Ohfuji, S., Kase, T., Kondo, K., Nakagama, Y., Nakagama, S., Nitahara, Y., Takahama, S., Kakeya, H., Appay, V., Fukushima, W., Kido, Y., & Yamamoto, T. (2026). Sustained antigen-specific CD8+ T cell immunity post–mRNA booster requires notch pathway activation. The Journal of Immunology, 215(6). https://doi.org/10.1093/jimmun/vkag074

Vancouver

Nogimori T, Okina Y, Masuta Y, Kumamoto M, Matsuura T, Kaku N, et al. Sustained antigen-specific CD8+ T cell immunity post–mRNA booster requires notch pathway activation. The Journal of Immunology. 2026;215(6). doi:10.1093/jimmun/vkag074

BibTeX
@article{Nogimori2026,
  author = {Nogimori, Takuto and Okina, Yoshinori and Masuta, Yuji and Kumamoto, Mayu and Matsuura, Tomoka and Kaku, Natsuko and Ohfuji, Satoko and Kase, Tetsuo and Kondo, Kyoko and Nakagama, Yu and Nakagama, Sachie and Nitahara, Yuko and Takahama, Shokichi and Kakeya, Hiroshi and Appay, Victor and Fukushima, Wakaba and Kido, Yasutoshi and Yamamoto, Takuya},
  title = {Sustained antigen-specific CD8+ T cell immunity post–mRNA booster requires notch pathway activation},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {6},
  doi = {10.1093/jimmun/vkag074}
}
Kostenlos starten →